Treatment of acral and mucosal melanoma: Current and emerging targeted therapies.

Abstract excerpt

Targeted therapies revolutionized the management of patients with advanced and metastatic cutaneous melanoma. However, despite recent advances in the understanding of the molecular drivers of melanoma and its treatment with targeted therapies, patients with rare and aggressive melanoma subtypes, including acral melanoma (AM) and mucosal melanomas (MM), show limited long-term clinical benefit from current targeted...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Melanoma
• Share to Mutation
• Share to Skin Neoplasms